Bullish & Foolish
Full DRIO fundamentals All 466 on the Survival Watch

DRIODarioHealth Corp.

Is DarioHealth struggling financially?

Yes, by its own account. DarioHealth told the SEC on 13 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$73.4M
Source filing
10-Q 13 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 3months

    If the burn speeds up

    Empty by Sep 2026

  • 5months

    If it eases off

    Empty by Nov 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$14.0M

÷

Cash burned over the last 12 months

$44.3M

What DarioHealth told the SEC

…ability to retain key executive members; our ability to internally develop new inventions and intellectual property; that our financial position raises substantial doubt about our ability to continue as a going concern; the ability to consummate a potential sale, merger or strategic business combination; general market, political and economic conditions in the countries in which we operate,…

DarioHealth Corp., Form 10-Q, filed 13 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • Debt pressure is material Operating earnings cover only -6.9x the interest bill, so the interest is being met out of cash reserves rather than out of the business.

Other Biotech/Pharma companies that filed the doubt